Stacey Anderson, MD, and Boris Kovatchev, PhD, co-directors of the Center for Diabetes Technology in the Division of Endocrinology, have been awarded a $12.7 million grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to conduct clinical trials for an artificial pancreas device developed at UVA.
The device, which automatically monitors and regulates blood-sugar levels in people with type 1 diabetes, will undergo final testing in two clinical trials beginning in early 2016. According to Dr. Anderson, “This is one of the largest-ever long-term clinical trials of the artificial pancreas in the patient’s natural environment. The ultimate goal is to establish the safety and efficacy of the system for regulatory approval and commercialization.”
Comments